Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

12.04 +0.19 (+1.60%)
Streaming Delayed Price Updated: 12:28 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
NEOGENOMICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NeoGenomics, Inc. (NEO)
From Robbins LLP
Via Business Wire
News headline image
NeoGenomics Announces Chief Financial Officer Transition
Via ACCESSWIRE
News headline image
Why Shares of NeoGenomics Jumped 53.9% This Week ↗
The cancer screening company showed its turnaround may be working. 
Via The Motley Fool
News headline image
EQUITY ALERT: Rosen Law Firm Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NEO
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
From Kirby McInerney LLP
Via Business Wire
News headline image
Where NeoGenomics Stands With Analysts ↗
Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings: 
Via Benzinga
News headline image
NeoGenomics Reports Third Quarter 2022 Results
Via ACCESSWIRE
News headline image
INVESTOR ALERT: NeoGenomics, Inc. Investors with Substantial Losses Have Opportunity to Lead the NeoGenomics Class Action Lawsuit - NEO
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
CORRECTING and REPLACING NEOGENOMICS INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit on Behalf of NEO Investors
From Gibbs Law Group
Via Business Wire
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Via ACCESSWIRE
Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease
Via ACCESSWIRE
News headline image
NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)
Via ACCESSWIRE
News headline image
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81% ↗
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to... 
Via Benzinga
News headline image
Earnings Scheduled For November 11, 2022 ↗
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is expected to report quarterly loss at $0.37 per share on revenue of $919.90 million. 
Via Benzinga
News headline image
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. 
Via Benzinga
News headline image
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday ↗
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors
Via ACCESSWIRE
News headline image
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... 
Via Benzinga
News headline image
If You Invested $1,000 In These 3 Crypto Tokens You Would Have This Much In Crypto Dividends ↗
When navigating the cryptocurrency market it can be difficult to distinguish between the “s— tokens” and tokens that actually provide value through a utility. 
Via Benzinga
News headline image
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
Via ACCESSWIRE
News headline image
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
News headline image
Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.